RaySearch Laboratories AB (publ) announced that The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), in the USA, has placed an order for the treatment planning system RayStation®. Revenue from the order will be recognized in the fourth quarter, 2022. The department of Radiation Oncology will utilize a Varian ProBeam® 360 for proton therapy, and also has several Varian linear accelerators in service. The OSUCCC - James will use the latest RayStation technologies, such as deep learning segmentation, image deformation, adaptive planning, multi-criteria optimization, and fallback planning, which allows for contingency planning and comparison of modalities to help clinicians select the most appropriate treatment technique.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
139.2 SEK | -0.14% |
|
+0.58% | +54.15% |
01/07 | RaySearch Releases RayStation 2024B | CI |
30/05 | RaySearch Laboratories AB Releases RayCare 2024A | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+54.15% | 45Cr | |
-3.52% | 3TCr | |
+40.70% | 947.14Cr | |
+31.92% | 432.97Cr | |
-41.69% | 220.87Cr | |
-6.10% | 166.3Cr | |
-40.78% | 101.17Cr | |
-4.87% | 85Cr | |
-51.15% | 68Cr | |
-31.34% | 60Cr |
- Stock Market
- Equities
- RAY B Stock
- News RaySearch Laboratories AB
- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Select RayStation for Proton Planning